Discovery of picomolar slow tight-binding inhibitors of α-fucosidase

Chemistry and Biology

Volumn 11, Issue 9, 2004, Pages 1301-1306

  Chang, Chuan Fa ^a   Ho, Chin Wen ^a   Wu, Chung Yi ^a   Chao, Tsrong An ^a   Wong, Chi Huey ^a,b   Lin, Chun Hung ^a  

^a INSTITUTE OF BIOLOGICAL CHEMISTRY   (Taiwan)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA LEVO FUCOSIDASE; DRUG DERIVATIVE; ENZYME INHIBITOR; FUCONOJIRIMYCIN; GLUCOSAMINE;

ARTICLE; CHEMICAL STRUCTURE; CHEMISTRY; COMBINATORIAL CHEMISTRY; CORYNEBACTERIUM; DRUG ANTAGONISM; ENZYMOLOGY; KINETICS; METABOLISM; METHODOLOGY; SPECTROFLUOROMETRY;

ALPHA-L-FUCOSIDASE; COMBINATORIAL CHEMISTRY TECHNIQUES; CORYNEBACTERIUM; ENZYME INHIBITORS; GLUCOSAMINE; KINETICS; MOLECULAR STRUCTURE; SPECTROMETRY, FLUORESCENCE;

CORYNEBACTERIUM; CORYNEBACTERIUM SP.; INFLUENZA VIRUS;

EID: 4644292902     PISSN: 10745521     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chembiol.2004.07.009     Document Type: Article

References (38)

1. Sels J.P., Huijberts M.S., Wolffenbuttel B.H. Miglitol, a new α-glucosidase inhibitor. Expert Opin. Pharmacother. 1:1999;149-156
2. Scott L.J., Spencer C.M. Miglitol. a review of its therapeutic potential in type 2 diabetes mellitus Drugs. 59:2000;521-549
3. Asano N. Glycosidase inhibitors. update and perspectives on practical use Glycobiology. 13:2003;93R-104R
4. Goss P.E., Baker M.A., Carver J.P., Dennis J.W. Inhibitors of carbohydrate processing. a new class of anticancer agents Clin. Cancer Res. 1:1995;935-944
5. Parish C.R., Freeman C., Hulett M.D. Heparanase. a key enzyme involved in cell invasion Biochim. Biophys. Acta. 1471:2001;M99-M108
6. Roth J., Zuber C., Guhl B., Fan J.Y., Ziak M. The importance of trimming reactions on asparagine-linked oligosaccharides for protein quality control. Histochem. Cell Biol. 117:2002;159-169
7. Herscovics A. Importance of glycosidases in mammalian glycoprotein biosynthesis. Biochim. Biophys. Acta. 1473:1999;96-107
8. Misaizu T., Matsuki S., Strickland T.W., Takeuchi M., Kobata A., Takasaki S. Role of antennary structure of N-linked sugar chains in renal handling of recombinant human erythropoietin. Blood. 86:1995;4097-4104
9. Lew W., Chen X., Kim C.U. Discovery and development of GS 4104 (oseltamivir). an orally active influenza neuraminidase inhibitor Curr. Med. Chem. 7:2000;663-672
10. Mitrakou A., Tountas N., Raptis A.E., Bauer R.J., Schulz H., Raptis S.A. Long-term effectiveness of a new α-glucosidase inhibitor (BAY m1099-miglitol) in insulin-treated type 2 diabetes mellitus. Diabet. Med. 15:1998;657-660
11. Moloney D.J., Shair L.H., Lu F.M., Xia J., Locke R., Matta K.L., Haltiwanger R.S. Mammalian Notch1 is modified with two unusual forms of O-linked glycosylation found on epidermal growth factor-like modules. J. Biol. Chem. 275:2000;9604-9611
12. Hooper L.V., Gordon J.I. Glycans as legislators of host-microbial interactions. spanning the spectrum from symbiosis to pathogenicity Glycobiology. 11:2001;1R-10R
13. Hiraishi K., Suzuki K., Hakomori S., Adachi M. Le(y) antigen expression is correlated with apoptosis (programmed cell death). Glycobiology. 3:1993;381-390
14. Sulzenbacher G., Bignon C., Nishimura T., Tarling C.A., Withers S.G., Henrissat B., Bourne Y. Crystal structure of Thermotoga maritima α-L-fucosidase. Insights into the catalytic mechanism and the molecular basis for fucosidosis. J. Biol. Chem. 279:2004;13119-13128
15. Tarling C.A., He S., Sulzenbacher G., Bignon C., Bourne Y., Henrissat B., Withers S.G. Identification of the catalytic nucleophile of the family 29 α-L-fucosidase from Thermotoga maritima through trapping of a covalent glycosyl-enzyme intermediate and mutagenesis. J. Biol. Chem. 278:2003;47394-47399
16. Lowe J.B. Glycosylation in the control of selectin counter-receptor structure and function. Immunol. Rev. 186:2002;19-36
17. Ayude D., Fernandez-Rodriguez J., Rodriguez-Berrocal F.J., Martinez-Zorzano V.S., de Carlos A., Gil E., de La Cadena M.P. Value of the serum α-L-fucosidase activity in the diagnosis of colorectal cancer. Oncology. 59:2000;310-316
18. Fernandez-Rodriguez J., Ayude D., de La Cadena M.P., Martinez-Zorzano V.S., de Carlos A., Caride-Castro A., de Castro G., Rodriguez-Berrocal F.J. α-L-fucosidase enzyme in the prediction of colorectal cancer patients at high risk of tumor recurrence. Cancer Detect. Prev. 24:2000;143-149
19. Glick M.C., Kothari V.A., Liu A., Stoykova L.I., Scanlin T.F. Activity of fucosyltransferases and altered glycosylation in cystic fibrosis airway epithelial cells. Biochimie. 83:2001;743-747
20. Scanlin T.F., Glick M.C. Terminal glycosylation in cystic fibrosis. Biochim. Biophys. Acta. 1455:1999;241-253
21. Giardina M.G., Matarazzo M., Morante R., Lucariello A., Varriale A., Guardasole V., De Marco G. Serum α-L-fucosidase activity and early detection of hepatocellular carcinoma. a prospective study of patients with cirrhosis Cancer. 83:1998;2468-2474
22. Wu C.-Y., Chang C.-F., Chen J.S.-Y., Wong C.-H., Lin C.-H. Rapid diversity-oriented synthesis followed by in situ screening. identification as potent and selective α-fucosidase inhibitors Angew. Chem. Int. Ed. Engl. 42:2003;4661-4664
23. Morrison J.F., Walsh C.T. The behavior and significance of slow-binding enzyme inhibitors. Adv. Enzymol. Relat. Areas Mol. Biol. 61:1988;201-301
24. Lin C.-H., Chen S., Kwon D.S., Coward J.K., Walsh C.T. Aldehyde and phosphinate analogs of glutathione and glutathionylspermidine. potent, selective binding inhibitors of the E. coli bifunctional glutathionylspermidine synthetase/amidase Chem. Biol. 4:1997;859-866
25. Matagne A., Ghuysen M.F., Frere J.M. Interactions between active-site-serine β-lactamases and mechanism-based inactivators. a kinetic study and an overview Biochem. J. 295:1993;705-711
26. Becker R.A., Scholkens B. Ramipril. review of pharmacology Am. J. Cardiol. 59:1987;3D-11D
27. Goli U.B., Galardy R.E. Kinetics of slow, tight-binding inhibitors of angiotensin converting enzyme. Biochemistry. 25:1986;7136-7142
28. Houtzager V., Ouellet M., Falgueyret J.P., Passmore L.A., Bayly C., Perciival M.D. Inhibitor-induced changes in the intrinsic fluorescence of human cyclooxygenase-2. Biochemistry. 35:1996;10974-10984
29. Pandhare J., Dash C., Rao M., Deshpande V. Slow tight-binding inhibition of proteinase K by a proteinaceous inhibitor. conformational alterations responsible for conferring irreversibility to the enzyme-inhibitor complex J. Biol. Chem. 278:2003;48735-48744
30. Dash C., Vathipadiekal V., George S.P., Rao M. Slow tight-binding inhibition of xylanase by an aspartic protease inhibitor. kinetic parameters and conformational changes that determine the affinity and selectivity of the bifunctional nature of the inhibitor J. Biol. Chem. 277:2002;17978-17986
31. Legler G. Glycoside hydrolases. mechanistic information from studies with reversible and irreversible inhibitors Tipson R.S., Horton D. Advances in Carbohydrate Chemistry and Biochemistry. 1990;319-384 Academic Press, San Diego
32. Lohse A., Hardlei T., Jensen A., Plesner I.W., Bols M. Investigation of the slow inhibition of almond β-glucosidase and yeast isomaltase by 1-azasugar inhibitors. evidence for the 'direct binding' model Biochem. J. 349:2000;211-215
33. Bulow A., Plesner I.W., Bols M. A large difference in the thermodynamics of binding of isofagomine and 1-deoxynojirimycin to β-glucosidase. J. Am. Chem. Soc. 122:2000;8567-8568
34. Schramm V.L. Enzymatic transition state poise and transition state analogs. Acc. Chem. Res. 36:2003;588-596
35. Lewandowicz A., Tyler P.C., Evans G.B., Furneaux R.H., Schramm V.L. Achieving the ultimate physiological goal in transition state analogue inhibitors for purine nucleoside phosphorylase. J. Biol. Chem. 278:2003;31465-31468
36. Fedorov A., Shi W., Kicska G., Fedorov E., Tyler P.C., Furneaux R.H., Hanson J.C., Gainsford G.J., Larese J.Z., Schramm V.L., et al. Transition state structure of purine nucleoside phosphorylase and principles of atomic motion in enzymatic catalysis. Biochemistry. 40:2001;853-860
37. Ponasik J.A., Strickland C., Faerman C., Savvides S., Karplus P.A., Ganem B. Kukoamine A and other hydrophobic acylpolyamines. potent and selective inhibitors of Crithidia fasciculata trypanothione reductase Biochem. J. 311:1995;371-375
38. Faerman C.H., Savvides S.N., Strickland C., Breidenbach M.A., Ponasik J.A., Ganem B., Ripoll D., Krauth-Siegel R.L., Karplus P.A. Charge is the major discriminating factor for glutathione reductase versus trypanothione reductase inhibitors. Bioorg. Med. Chem. 4:1996;1247-1253